Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2015-07-01 Board/Management Inform…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Elos Medtech Tianjins VD i Kina avgår
Board/Management Information Classification · 98% confidence The document is a press release announcing the resignation of the CEO/Site Manager (VD/Platschef) Jurgen Moortgat from Elos Medtech Tianjin in China. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The relevant code is MANG.
2015-07-01 Swedish
Elos förtydligar inriktningen – ändrar namnet till Elos Medtech
AGM Information Classification · 99% confidence The document is titled "*Pressrelease*" and announces a name change for the company from Elos AB (publ) to Elos Medtech AB, effective following the Annual General Meeting (AGM) decision on April 27, 2015. It discusses strategic focus, recent divestitures/acquisitions, and the rationale for the name change, concluding with a date (May 22, 2015) and contact information, typical of a corporate announcement. Since the document is a press release announcing a strategic corporate action (name change) that affects its identity and market perception, it does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a general corporate update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general regulatory announcement that isn't a specific financial report or management change, although 'SHA' (Share Issue/Capital Change) might be considered if the name change was tied to a capital structure event, which it is not explicitly. However, since it is a general press release about a corporate identity change, RNS serves as the best general regulatory announcement category.
2015-05-22 Swedish
Elos AB (publ) – Årsstämma 2015
AGM Information Classification · 98% confidence The document is titled 'Elos AB (publ) – Årsstämma 2015' (Annual General Meeting 2015) and details the resolutions passed during this meeting, such as dividend approval, company name change, and board member elections. This content directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the Q1 2015 report, the primary focus and structure are clearly summarizing the outcomes of the Annual General Meeting.
2015-04-28 Swedish
Elos AB (publ) – Annual General Meeting 2015
AGM Information Classification · 98% confidence The document explicitly states it concerns the 'Annual General Meeting 2015' and details resolutions passed at this meeting, such as dividend approval, name change, and board member elections. This directly aligns with the definition of 'AGM Information' (Code: AGM-R). Although it mentions the dividend (DIV) and board changes (MANG), the overarching context is the summary of the AGM proceedings.
2015-04-28 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January – 31 March 2015. It contains comprehensive financial statements, including income statements, balance sheets, cash flow data, and management commentary on business performance, segments, and risks. It is not a mere announcement (RPA) as it provides the full substantive financial data for the quarter. Therefore, it is classified as an Interim/Quarterly Report. Q1 2015
2015-04-27 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report, 1 January–31 March 2015' and contains comprehensive financial statements, management commentary, segment reporting, and notes on accounting policies for a specific fiscal period. It is clearly a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-04-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.